Search

everythinglearnresearchcommunity

for

Search:↓

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.